Alliqua BioMedical, Inc. is a biomedical products company based in Wrentham, MA, specializing in the development and manufacturing of electron-beam cross-linked hydrogels for the original equipment manufacturer market. With their hydrogel platform, they are able to produce custom sheet gels with or without active ingredients, effectively delivering prescription or over-the-counter medications, wound healing materials, and skincare ingredients. Operating a state-of-the-art manufacturing facility in Langhorne, PA, Alliqua BioMedical is committed to providing high-quality custom hydrogels to meet the diverse needs of their customers.
Alliqua BioMedical has made significant strides in the biomedical industry, with recent news and developments including the spin-off and merger of their Contract Manufacturing Business with TO Pharmaceuticals LLC to create an independent, publicly traded company focused on cannabinoid-based pharmaceutical therapies. Additionally, they have announced a merger agreement with Adynxx, Inc. to establish a NASDAQ-listed clinical-stage pharmaceutical company with a focus on pain and inflammation. With a strong commitment to innovation and growth, Alliqua BioMedical continues to make advancements in the field of biomedical products.
Generated from the website